Concepedia

ICAM-1 Mediated Peritoneal Carcinomatosis, A Target for Therapeutic Intervention

Nawar A. Alkhamesi, Paul Ziprin, Katherine L. M. Pfistermüller, David H. Peck, Ara Darzi

Clinical & Experimental Metastasis · 2005 · 63 citations · 39 references

DOI

Concepts

References

39

Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS)

Ajay K. Kakkar, Mark N. Levine, Zbigniew Kadziola et al. · Journal of Clinical Oncology · 2004 · 654 citations · Full text

, , +13

Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.

G Omura, Mark F. Brady, Howard D. Homesley et al. · Journal of Clinical Oncology · 1991 · 469 citations

, , +16

Isolation, culture and characterization of human peritoneal mesothelial cells

Eleni Stylianou, L. A. Jenner, Malcolm Davies et al. · Kidney International · 1990 · 395 citations · Full text

, , +4

CD44 and β1 Integrin Mediate Ovarian Carcinoma Cell Adhesion to Peritoneal Mesothelial Cells

Khashayar Lessan, Dean J. Aguiar, Theodore R. Oegema et al. · American Journal Of Pathology · 1999 · 224 citations · Full text

, , +12

Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.

A. M. M. Eggermont, E P Steller, Paul H. Sugarbaker · PubMed · 1987 · 218 citations

, , +13